Featured news in The Life Sciences Report



Sproutly Canada Inc. (SPR:CSE;SRUTF:OTCQB)
The Future of Beverages in the Cannabis Sector: Sproutly (CSE: SPR) (OTCQB: SRUTF), Hexo Corp., The Green Organic Dutchman Ltd. (11/8/2018)

view
 


DURECT Corp. (DRRX:NASDAQ)
DURECT Corporation Announces Third Quarter 2018 Financial Results and Provides Corporate Update (11/7/2018)

view
 


Caladrius Biosciences Inc. (CLBS:NASDAQ)
Caladrius Biosciences Appoints Cynthia Schwalm to Board of Directors (11/8/2018)

view
 


Celgene Corp. (CELG:NASDAQ)
Prothena (PRTA) Reports Narrower-Than-Expected Loss in Q3 (11/8/2018)

view
 


MiMedx Group Inc. (MDXG:NASDAQ)
Jack Henry & Associates Set to Join S&P 500; EQT, Equitrans Midstream, MasTec to Join S&P MidCap 400; Superior Energy Services, United Natural Foods to Join S&P SmallCap 600 (11/7/2018)

view
 

MiMedx Group Inc. (MDXG:NASDAQ)
Today's Research Reports on Trending Tickers: Tandem Diabetes Care and MiMedx (11/8/2018)

view
 


Cesca Therapeutics Inc. (KOOL:NASDAQ)
Cesca Therapeutics To Announce Financial Results For The Third Quarter Ended September 30, 2018 And Host Conference Call On November 14 (11/7/2018)

view
 

Cesca Therapeutics Inc. (KOOL:NASDAQ)
Will Cesca Therapeutics (KOOL) Report Negative Earnings Next Week? What You Should Know (11/6/2018)

view
 


Athersys Inc. (ATHX:NASDAQ)
Athersys Reports Third Quarter 2018 Results (11/6/2018)

view
 


MiMedx Group Inc. (MDXG:NASDAQ)
MiMedx Receives Nasdaq Delisting Notification (11/7/2018)

view
 

MiMedx Group Inc. (MDXG:NASDAQ)
MiMedx To Present Clinical And Scientific Studies At Desert Foot Conference (11/6/2018)

view
 

MiMedx Group Inc. (MDXG:NASDAQ)
MiMedx Adopts Limited Duration Shareholder Rights Plan In Response To Delisting From Nasdaq (11/7/2018)

view
 


BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
BrainStorm Cell Therapeutics to Present at November Clinical and Investor Conferences (11/7/2018)

view
 


ProMIS Neurosciences Inc. (PMN:TSX; ARFXF:OTCQB)
ProMIS Neurosciences Discusses Critical Importance of Selectively Targeting the Root Cause of Alzheimer's Disease (11/6/2018)

view
 


RepliCel Life Sciences Inc. (RP:TSX.V; REPCF:OTCQB)
RepliCel Life Sciences Appoints Head of Clinical and Regulatory Affairs (11/6/2018)

view
 


Celgene Corp. (CELG:NASDAQ)
Corcept (CORT) Q3 Earnings In Line, Revenues Miss Estimates (11/5/2018)

view